Henry Ford Health System
Detroit, Michigan, 48202, United States
NCT Number: NCT05138328
This pilot study will examine the treatment of basal cell carcinoma (BCC) with laser technology under the guidance of imaging modalities to assist with surgical excision, including optical coherence tomography imaging (OCT) and reflectance confocal microscopy (RCM). The laser modality that we plan to use is the long-pulse Nd:YAG 1064nm laser, which is a nonablative laser already shown to effectively treat BCC. The addition of OCT and RCM has the opportunity to enhance outcomes by better targeting the treatment and permitting more precise monitoring of clearance. OCT is being used to enhance the effectiveness of Mohs Micrographic Surgery of these cancers by elucidating more definitive tumor margins. RCM has been shown to detect changes in the composition of cells consistent with BCC.
We propose to use these imaging devices to guide the laser treatment to achieve optimal efficacy with minimized side-effects. Primary outcome measured include complete clearance of the BCC lesion, which will be determined through clinical examination, dermoscopy, imaging (OCT and/or RCM), and saucerization biopsy. Secondary outcome variables include the significance of lesion depth (by OCT and/or RCM), lateral extent (by OCT and/or RCM), BCC type, and anatomical region on rate of clearance and recurrence.
Looking for future studies?
Notify Me18 year–105 year
All sexes
Interventional
Not applicable
Detroit, Michigan, 48202, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This will use optical coherence tomography (OCT) to assess the margins of basal cell carcinoma. Treatment will be completed by Nd:YAG laser.
Time frame: 3-15 months after treatment
Clearance of BCC as indicated by imaging of optical coherence tomography (OCT)
Time frame: 3-15 months after treatment
Clearance of BCC as indicated by biopsy
Henry Ford Health System
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01455363
Carcinoma, Carcinoma, Basal Cell
Paris, France
View Trial DetailsNCT03897036
Carcinoma, Carcinoma, Basal Cell
Scottsdale, Arizona, United States
View Trial DetailsNCT03132636
Carcinoma, Carcinoma, Basal Cell
Phoenix, Arizona, United States
View Trial DetailsNCT00218868
Carcinoma, Carcinoma, Basal Cell
Trondheim, Norway
View Trial Details